Drug shows promise for Huntington's disease
Tuesday, February 9, 2010 - 00:28
in Health & Medicine
An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition. That is the conclusion of a study published today in the Archives of Neurology.